Surgical vs TranscatheterWednesday, May 27, 2026

Prognostic Impact of Baseline Albumin-Bilirubin Score on Mortality After Transcatheter Edge-to-Edge Mitral Repair.

2 min read·By E. Nolan Beckett, MD·Source: Medicina (Kaunas, Lithuania)

Key Numbers

28.3%

95% CI 1

p = 0.004

p = 0.005

From The Valve Wire

This single-center retrospective cohort of 106 TEER patients (January 2019 to December 2025) evaluated the albumin-bilirubin (ALBI) score as a mortality predictor.

Over a median 17.9-month follow-up, 28.3% died.

On LASSO-selected ridge-penalized multivariable Cox modeling, ALBI score (HR 3.35, 95% CI 1.46-7.71, p=0.004), LAVI (HR 1.02 per unit), and log-BNP (HR 1.37) independently predicted mortality.

Adding ALBI to the base model raised the C-index from 0.845 to 0.886, with an ROC AUC of 0.877 and an optimal cutoff of -1.67.

Source Abstract

Background and Objectives: Transcatheter edge-to-edge repair (TEER) has emerged as an effective treatment option for patients with severe mitral regurgitation who are at high surgical risk. However, clinical outcomes after TEER remain heterogeneous and are influenced not only by cardiac parameters but also by systemic comorbidities and multiorgan dysfunction. The albumin-bilirubin (ALBI) score, derived from serum albumin and bilirubin levels, has recently been proposed as a simple marker of hepatic dysfunction and cardio-hepatic interaction. This study aimed to evaluate the prognostic value of baseline ALBI score in predicting long-term mortality after TEER. Materials and Methods: In this single-center retrospective cohort study, 106 consecutive patients with symptomatic moderate-to-severe or severe mitral regurgitation who underwent TEER between January 2019 and December 2025 were included. Baseline ALBI score was calculated using pre-procedural serum albumin and bilirubin levels. Cox proportional hazards regression analysis was used to identify predictors of long-term mortality. Variable selection was performed using least absolute shrinkage and selection operator (LASSO) regression, followed by ridge-penalized multivariable Cox modeling to minimize overfitting. The incremental prognostic value of ALBI was assessed using concordance index (C-index) comparison between predictive models. Receiver operating characteristic (ROC) analysis and Kaplan-Meier survival analysis were also performed. Results: During a median follow-up of 17.9 months, 30 patients (28.3%) died. Higher baseline ALBI scores were significantly associated with increased mortality risk. In multivariable analysis, ALBI score (HR 3.35, 95% CI 1.46-7.71; p = 0.004), left atrial volume index (LAVI) (HR 1.02, 95% CI 1.01-1.03; p = 0.005), and log-transformed B-type natriuretic peptide (BNP) (HR 1.37, 95% CI 1.02-1.86; p = 0.039) remained independent predictors of mortality. Addition of the ALBI score improved model discrimination, increasing the C-index from 0.845 to 0.886. ROC analysis demonstrated good predictive performance of the ALBI score (area under the curve [AUC] = 0.877), with an optimal cut-off value of -1.67. Conclusions: Baseline ALBI score is independently associated with long-term mortality after TEER and may provide potential incremental prognostic information. However, the observed improvement is modest and should be interpreted cautiously. These findings support a potential role of ALBI as a complementary marker, which requires validation in larger prospective studies.

Authors: Savur Ü, Keskin B, Akhundova A, Hakgor A, Güneş HM et al.

Read the Original

Full article at Medicina (Kaunas, Lithuania)

Open at Medicina (Kaunas, Lithuania) →

The Valve Wire summarizes; we link out to primary sources for verification.